Chemours (CC) Non-Current Deffered Revenue (2015 - 2021)

Chemours has reported Non-Current Deffered Revenue for 7 years, with the latest figure at $2.0 million in Q4 2021.

• For the quarter ending Q4 2021, Non-Current Deffered Revenue fell 60.0% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2021 stood at $2.0 million (down 60.0% YoY), and the FY2021 full-year result was $2.0 million, down 60.0% from the prior year.
• Non-Current Deffered Revenue for Q4 2021 stood at $2.0 million, down from $5.0 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $8.0 million in Q3 2018, with the low at $2.0 million in Q4 2021.
• Average Non-Current Deffered Revenue over 5 years is $5.5 million, with a median of $5.0 million recorded in 2018.
• Year-over-year, Non-Current Deffered Revenue grew 20.0% in 2017 and sank 60.0% in 2021.
• Tracing CC's Non-Current Deffered Revenue over 5 years: stood at $6.0 million in 2017, then advanced by 16.67% to $7.0 million in 2018, then gained by 14.29% to $8.0 million in 2019, then plunged by 37.5% to $5.0 million in 2020, then slumped by 60.0% to $2.0 million in 2021.
• The last three Non-Current Deffered Revenue figures came in at $2.0 million (Q4 2021), $5.0 million (Q3 2021), and $5.0 million (Q2 2021), per Business Quant data.

Peer Comparison